Summary
For Year 2026-27, Jagsonpal Pharmaceuticals reports the following shareholding: Total Promoters at 67.89%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 2.44%, Domestic Institutional Investors at 0.22%, and Retail at 29.45%. This breakdown provides a quick snapshot of ownership distribution for Jagsonpal Pharmaceuticals in 2026-27.
Jagsonpal Pharmaceuticals FAQs
As of 05-2026, the promoter shareholding in Jagsonpal Pharmaceuticals stands at 67.89% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Jagsonpal Pharmaceuticals is 2.44% and 0.22% respectively.
The retail shareholding of the Jagsonpal Pharmaceuticals is 29.45%.
Changes in shareholding patterns of Jagsonpal Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Jagsonpal Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Jagsonpal Pharmaceuticals Associated Pages
- Jagsonpal Pharmaceuticals Share Price
- Jagsonpal Pharmaceuticals Share Price chart
- Jagsonpal Pharmaceuticals Fundamental Analysis
- Jagsonpal Pharmaceuticals Technical Analysis
- Jagsonpal Pharmaceuticals Peer Comparison
- Jagsonpal Pharmaceuticals Share Price History
- Jagsonpal Pharmaceuticals Stock Split
- Jagsonpal Pharmaceuticals Dividend
- Jagsonpal Pharmaceuticals Board of Directors
